Netanel Derovan - Jan 9, 2022 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role: Chief Legal Officer
Signature: /s/ Netanel Derovan
Stock symbol: ORMP
Transactions as of: Jan 9, 2022
Transactions value $: $0
Form type: 4
Date filed: 1/11/2022, 07:40 PM
Next filing: Aug 1, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ORMP	Common Stock	Award		+18K			18K	Jan 9, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ORMP	Stock Option (right to buy)	Award	$0	+30K		$0.00	30K	Jan 9, 2022	Common Stock	30K	$12.03	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 4,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
F2	The Stock Option will vest in 4 installments as follows: 7,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.